COVID-19-induced rhabdomyolysis in an adolescent: A rare presentation
DOI:
https://doi.org/10.25753/BirthGrowthMJ.v31.i3.27608Keywords:
COVID-19, muscle, myositis, rhabdomyolysisAbstract
Viral infections are a well-known cause of myositis. The clinical presentation may vary from mild myalgia to severe muscle injury. Coronavirus disease 2019 (COVID-19), a viral respiratory disease caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), can be a cause of myositis and of rhabdomyolysis, a rare and severe complication.
A previously healthy 11-year-old female adolescent with COVID-19 presented to the Emergency Department with lower limb pain and inability to walk. The initial laboratory study revealed a marked elevation of muscular enzymes, particularly creatine kinase (13046 UI/L; reference value 149 UI/L). Urine dipstick test reacted positively for hemoglobinuria. The patient started treatment with aggressive intravenous hydration, with progressive clinical and analytical improvement.
Musculoskeletal symptoms associated with COVID-19 are a frequent complaint, with potentially severe complications, such as rhabdomyolysis. A proper and timely diagnosis can prevent further clinical deterioration and enable adequate treatment and follow-up.
Downloads
References
Bhai S, Naddaf E, Dimachkie MM. Overview of viral myositis. Last updated May 31,2022 (Assessed June 15, 2022). Available at: https://www.uptodate.com/contents/overview-of-viral-myositis?source=history_widget.
Tekin E, Akoglu HA. From Influenza to SARS-CoV-2: etiological evaluation of acute benign childhood myositis. Acta Neurol Belg 2022;122(4):1043-1047. https://doi.org/10.1007/s13760-021-01785-0.
Uslu S. Myositis due to COVID-19. Postgrad Med J. 2021;97(1148):399. https://doi.org/10.1136/postgradmedj-2021-139725.
Mughal MS, Kaur IP, Alhashemi R, Rehman R, Du D. Acute viral myositis complicated by rhabdomyolysis: a sole manifestation of COVID-19 infection. J Community Hosp Intern Med Perspect. 2021;11(2):289-291. https://doi.org/10.1080/20009666.2021.1878601.
Saud A, Naveen R, Aggarwal R, Gupta L. COVID-19 and Myositis: What We Know So Far. Curr Rheumatol Rep. 2021;23(8):63 . https://doi.org/10.1007/s11926-021-01023-9.
Case SM, Son MB. COVID-19 in pediatrics. Rheum Dis Clin North Am. 2021;47(4):797-811. https://doi.org/10.1016/j.rdc.2021.07.006.
Cassim F, Soni AJ, Murphy S. Severe acute inflammatory myositis and rhabdomyolysis in paediatric SARS-CoV-2 associated MIS-C (multisystem inflammatory syndrome in children). BMJ Case Rep 2021;14(8):e243112. https://doi.org/10.1136/bcr-2021- 243112.
Zang H, Charmchi Z, Seidman RJ, Anziska Y, Velayudhan V, Perk J. COVID-19 associated myositis with severe proximal and bulbar weakness. Muscle Nerve. 2020;62(3):E57-E60. https://doi.org/10.1002/mus.27003.
Orsucci D, Ienco EC, Nocita G, Napolitano A, Vista M. Neurological features of COVID-19 and their treatment: a review. Drugs Context. 2020;9:2020-5-1. https://doi.org/10.7573/dic.2020-5-1.
Hannah JR, Ali SS, Nagra D, Adas MA, Buazon AD, Galloway JD, et al. Skeletal muscles and COVID-19: a systematic review of rhabdomyolysis and myositis in SARS-CoV-2 infection. Clin Exp Rheumatol. 2022;40(2):329-338. https://doi.org/10.55563/clinexprheumatol/mkfmxt.
Samies NL, Pinninti S, James SH. Rhabdomyolysis and Acute Renal Failure in an Adolescent With Coronavirus Disease 2019. J Pediatric Infect Dis Soc. 2020;9(4):507-509. https://doi.org/10.1093/jpids/piaa083.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 Rita Calejo, Joana Queirós; Carla Brandão; Fábio Barroso, Leonilde Machado
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Copyright and access
This journal offers immediate free access to its content, following the principle that providing free scientific knowledge to the public provides greater global democratization of knowledge.
The works are licensed under a Creative Commons Attribution Non-commercial 4.0 International license.
Nascer e Crescer – Birth and Growth Medical Journal do not charge any submission or processing fee to the articles submitted.